Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure

NCT04353206 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped The initiation of the expanded access program for convalescent plasma.

Conditions

Covid-19
Sars-CoV2

Interventions

BIOLOGICAL: Multiple Doses of Anti-SARS-CoV-2 convalescent plasma

Sponsor

Noah Merin

Collaborators

[object Object]